- Home
- ENVB vs XPON Comparison
ENVB vs XPON Comparison
Compare ENVB & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- XPON
- Stock Information
- Founded
- ENVB 1994
- XPON 2016
- Country
- ENVB United States
- XPON United States
- Employees
- ENVB N/A
- XPON N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- XPON Electronic Components
- Sector
- ENVB Health Care
- XPON Technology
- Exchange
- ENVB Nasdaq
- XPON Nasdaq
- Market Cap
- ENVB 3.1M
- XPON 3.2M
- IPO Year
- ENVB N/A
- XPON 2022
- Fundamental
- Price
- ENVB $1.29
- XPON $0.88
- Analyst Decision
- ENVB Strong Buy
- XPON
- Analyst Count
- ENVB 1
- XPON 0
- Target Price
- ENVB $10.00
- XPON N/A
- AVG Volume (30 Days)
- ENVB 225.8K
- XPON 62.6K
- Earning Date
- ENVB 08-11-2025
- XPON 08-13-2025
- Dividend Yield
- ENVB N/A
- XPON N/A
- EPS Growth
- ENVB N/A
- XPON N/A
- EPS
- ENVB N/A
- XPON N/A
- Revenue
- ENVB N/A
- XPON $6,702,411.00
- Revenue This Year
- ENVB N/A
- XPON $61.26
- Revenue Next Year
- ENVB N/A
- XPON N/A
- P/E Ratio
- ENVB N/A
- XPON N/A
- Revenue Growth
- ENVB N/A
- XPON 23.07
- 52 Week Low
- ENVB $1.01
- XPON $0.60
- 52 Week High
- ENVB $11.55
- XPON $121.41
- Technical
- Relative Strength Index (RSI)
- ENVB 45.37
- XPON 46.03
- Support Level
- ENVB $1.18
- XPON $0.87
- Resistance Level
- ENVB $1.31
- XPON $1.00
- Average True Range (ATR)
- ENVB 0.07
- XPON 0.07
- MACD
- ENVB 0.02
- XPON -0.00
- Stochastic Oscillator
- ENVB 46.56
- XPON 5.31
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.